Wuchter C, Harbott J, Schoch C, Schnittger S, Borkhardt A, Karawajew L, Ratei R, Ruppert V, Haferlach T, Creutzig U, D�rken B, Ludwig W-D: Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Leukemia 14: 1232-1238, 2000

  Wuchter C, Karawajew L, Ruppert V, Schrappe M, Harbott J, Ratei R, D�rken B, Ludwig W-D: Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukemia.
Br. J. Haematol. 110: 154-160, 2000

  Karawajew L, Ruppert V, Wuchter C, K�sser A, Schrappe M, D�rken B, Ludwig W-D: Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia.
Blood 96: 297-306, 2000

  Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, D�rken B, Ludwig WD, Karawajew L: In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Leukemia. 15: 921-8, 2001

  Borkhardt A, Wuchter C, Viehmann S, Pils S, Teigler-Schlegel A, Stanulla M, Zimmermann M, Ludwig WD, Janka-Schaub G, Schrappe M, Harbott J: Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of  77 cases.
Leukemia. 16: 1685-90, 2002

  Schabath R, Ratei R, Ludwig WD: The prognostic significance of antigen expression in leukaemia.
Best Pract Res Clin Haematol. 16: 613-628, 2003

  Bene MC, Castoldi G, Knapp W, Rigolin GM, Escribano L, Lemez P, Ludwig WD, Matutes E, Orfao A, Lanza F, Van�t Veer M. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
Leukemia. 18: 394-400, 2003

  Ludwig WD, Haferlach T, Schoch C: Classification of Acute Leukemias: Perspective 1,
In: Treatment of Acute Leukemias: New Directions for Clinical Research, Pui CH, Editor, Humana Press Inc.: Totowa, NJ. 3-41, 2003

  Ratei R, Ludwig WD: Flow-Cytometry Methods for the Detection of Residual Leukemia,
In: Leukemia and Lymphoma: Detection of Minimal Residual Disease, Zipf TF, Johnston DA, Editor, Humana Press Inc.: Totowa, NJ. 1-19, 2003

  Wuchter C, Richter S, Oltersdorf D, Karawajew L, Ludwig WD, Tamm I: Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemia.
Haematologica. 89: 363-4, 2004

  Dworzak MN, Froschl G, Printz D, Zen LD, Gaipa G, Ratei R, Basso G, Biondi A, Ludwig WD, Gadner H: CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease.
Leukemia, 18: 703-8, 2004

  Karawajew L, Rhein P, Czerwony G, Ludwig WD. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species.
Blood 105: 4767-75, 2005

  Ludwig WD, Bettelheim P: Immunph�notypisierung von akuten Leuk�mien und Non-Hodgkin-Lymphomen. 
In: Labor und Diagnose. 6. Auflage. Thomas L (Hrsg.), 2005

  Stanulla M, Schaeffeler E, Flohr T, Cario G, Schrauder A, Zimmermann M, Welte K, Ludwig WD, Bartram CR, Zanger UM, Eichelbaum M, Schrappe M, Schwab M. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia.
JAMA, 293: 1485-9, 2005